Raymond James Financial
MEDP icon

Raymond James Financial’s Medpace MEDP Stock Holding History

Raymond James Financial’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.8M Sell
126,182
-5,191
-4% -$2.4M 0.02% 779
2026
Q1 		$62.2M Buy
131,373
+42,079
+47% +$21.5M 0.02% 742
2025
Q4 		$50.2M Sell
89,294
-15,893
-15% -$9.02M 0.02% 817
2025
Q3 		$54.1M Sell
105,187
-16,073
-13% -$7.02M 0.02% 765
2025
Q2 		$38.1M Sell
121,260
-105,940
-47% -$31.8M 0.01% 933
2025
Q1 		$69.2M Sell
227,200
-8,011
-3% -$2.69M 0.03% 567
2024
Q4 		$78.1M Buy
+235,211
New +$79.8M 0.03% 512

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Raymond James Financial's MEDP Position: Q2 2026 in Review

Raymond James Financial reduced its Medpace (MEDP) stake by 4% in Q2 2026, selling an estimated $2.4M and leaving 126,182 shares worth $66.8M. The position accounts for 0.02% of the portfolio, ranked #779.

Raymond James Financial first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $78.1M in Q4 2024. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Raymond James Financial held 126,182 shares of Medpace worth $66.8M as of Q2 2026.
  • Raymond James Financial sold 5,191 Medpace shares in Q2 2026, an estimated $2.4M.
  • Medpace made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #779 holding.
  • Raymond James Financial first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Medpace position peaked at $78.1M in Q4 2024.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.